{"filings":[{"id":501516,"accession_number":"0001193125-26-229138","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-05-18T21:15:03+00:00","items":["8.01"],"status":"ready","headline":"Acadia subsidiary faces $105M jury verdict in retaliatory termination suit","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["San Diego jury awarded $35M compensatory and $70M punitive damages on May 12, 2026.","Plaintiff is a former employee of Fashion Valley CTC terminated in October 2023.","Acadia and Fashion Valley deny allegations and will challenge verdict in post-trial motions and appeal.","Company is not a party to the lawsuit; Fashion Valley is an indirect wholly owned subsidiary.","Acadia warns final outcome may differ materially due to uncertainties in litigation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93386,"accession_number":"0001193125-26-209324","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Acadia Healthcare annual meeting: directors elected, incentive plan and say-on-pay approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Three Class III directors elected with >73M votes each: Cancelmi, Fucci, Harris.","Second amendment to Incentive Compensation Plan approved: 80.1M for, 0.78M against, 0.05M abstain.","Non-binding say-on-pay passed with 60.9M for (75.3%) but 19.9M against (24.6%).","Ernst & Young ratified as auditor for FY 2026: 83.9M for, 1.95M against, 0.05M abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93385,"accession_number":"0001437749-26-013916","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare Q1 revenue up 7.6% to $828.8M; raises FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $828.8M (+7.6% YoY); same-facility revenue +7.3%.","Adjusted EPS $0.37 vs $0.40 prior year; GAAP EPS $0.05 vs $0.09.","Adjusted EBITDA $144.2M vs $134.2M prior year (+7.5%).","Added 82 newly licensed beds in Q1; full-year adjusted EBITDA and EPS guidance raised.","Revenue per patient day +5.6%; patient days +1.6%."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":828802000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93384,"accession_number":"0001193125-26-173769","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-04-23T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare CFO Todd Young departs; former CFO David Duckworth returns as Interim CFO; guidance reaffirmed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Todd Young resigns as CFO effective April 30, 2026; to join private equity-backed animal health company.","David Duckworth, former Acadia CFO (2012-2023), appointed Interim CFO effective May 1, 2026.","Interim CFO Duckworth to serve at least until permanent CEO search concludes; base salary $100K/month + $125K/quarter bonus.","Q1 2026 outlook reaffirmed: revenue $820-$830M, adj. EBITDA $130-$137M, adj. EPS $0.25-$0.30.","FY2026 guidance reaffirmed: revenue $3.37-$3.45B, adj. EBITDA $575-$610M, adj. EPS $1.30-$1.55; Q1 earnings call Apr 30."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104957,"accession_number":"0001193125-26-104272","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare appoints Dan Cancelmi to board; Wade Miquelon to retire at 2026 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Daniel Cancelmi, former Tenet Healthcare EVP & CFO, appointed to Acadia's Board effective March 12, 2026.","Wade Miquelon will retire from the Board at the 2026 annual meeting; not standing for re-election, no disagreement.","Board size increased from 10 to 11 then will reduce to 10 after Miquelon's retirement.","Appointment follows engagement with Khrom Capital; Goldman Sachs, J.P. Morgan financial advisors.","Company states it 'continues evaluating all paths to deliver enhanced shareholder value.'"],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104956,"accession_number":"0001437749-26-005431","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare Q4 net loss $13.02/sh on $996M goodwill impairment; appoints new CEO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $821.5M (+6.1% YoY); net loss $13.02/diluted share from $996.2M goodwill impairment.","Adjusted EBITDA $99.8M (down 35% YoY) includes $52.7M PLGL reserve adjustment.","FY 2025 adjusted EPS $2.00 vs $3.30; FY 2026 guidance: rev $3.37-3.45B, adj EPS $1.30-1.55.","Debbie Osteen appointed CEO; full-year 2025 added 1,089 licensed beds."],"consensus_eps_estimate":null,"consensus_eps_actual":-12.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":3312769000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104955,"accession_number":"0001193125-26-020169","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-01-23T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CEO Christopher H. Hunter departs Acadia Healthcare effective Jan 20, 2026; separation agreement disclosed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Christopher H. Hunter resigned and left Board effective Jan 20, 2026; no successor named.","Hunter will receive 1.5x base salary plus target bonus payable over 18 months, plus $1.785M retention bonus.","Unvested equity awards forfeited except prorated PSUs based on time elapsed and performance.","Separation conditions include general release of claims and continued compliance with restrictive covenants.","Company retains cooperation rights; Hunter must return company property within two days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104954,"accession_number":"0001437749-26-001486","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare appoints former CEO Debra Osteen as CEO; Chris Hunter departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Debra Osteen appointed CEO and Class I director effective January 20, 2026; previously served as CEO from 2018-2022.","Chris Hunter departed as CEO and resigned from Board effective January 20, 2026; separation agreement terms to be disclosed later.","Osteen receives base salary of $1,061,000, target bonus of 125% of salary, and option to purchase 1,125,000 shares with performance-based vesting.","Company reaffirms FY 2025 guidance: revenue $3.28B-$3.30B, Adjusted EBITDA $601M-$611M, adjusted EPS $1.94-$2.04.","Board will conduct a comprehensive search for a long-term successor while evaluating all paths to enhance shareholder value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104953,"accession_number":"0001437749-26-001137","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare reaffirms 2025 revenue $3.28-3.30B, adj. EBITDA $601-611M, adj. EPS $1.94-2.04","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirmed 2025 guidance at J.P. Morgan Healthcare Conference: revenue $3.28B-$3.30B.","Adjusted EBITDA guidance $601M-$611M; adjusted EPS guidance $1.94-$2.04.","Guidance originally given Nov 5, 2025, updated Dec 2, 2025; no changes.","Presentation webcast on Jan 13, 2026; slides available on company's website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121213,"accession_number":"0001437749-25-036657","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-12-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Acadia Healthcare lowers 2025 guidance after actuarial review shows $49M PLGL expense increase","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Adjusted EBITDA guidance reduced to $601-611M from $650-660M; adjusted EPS to $1.94-2.04 from $2.35-2.45.","2025 PLGL expense projected ~$116M, up from $54M in 2024, driven by 168% increase in claim frequency for 2025 policy year.","Net PLGL liability expected to rise to $145-165M at year-end 2025 from $78M at end of 2024.","For 2026, PLGL expense expected between $100M and $110M, reflecting assumption of sustained claim frequency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121212,"accession_number":"0001193125-25-274380","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Acadia Healthcare settles securities class action for $179M; no admission of liability","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Settlement of $179M resolves St. Clair County ER Sys. v. Acadia Healthcare case with no admission of liability.","Company expects ~$30M from insurance; balance funded from cash on hand and existing credit lines.","Aggregate settlement expensed in Q4 2025; excluded from adjusted EBITDA, no impact on guidance.","As of Sept 30, 2025: cash $118.7M, revolver availability $786.7M, net leverage ratio 3.4x."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121211,"accession_number":"0001437749-25-033347","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Acadia Q3 revenue $851.6M (+4.4% YoY), net income falls; cuts full-year guidance; COO resigns","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net income $36.2M ($0.40 diluted) vs $0.74 prior year; adjusted EPS $0.72 vs $0.91.","Adjusted EBITDA $173.0M, down from $194.3M; revenue $851.6M (+4.4%) but missed expectations.","Full-year guidance lowered: revenue $3.28-3.30B (prev $3.30-3.35B); adj EBITDA $650-660M (prev $675-700M); adj EPS $2.35-2.45 (prev $2.45-2.65).","COO Dr. Nasser Khan resigned effective Nov 3; he becomes executive advisor through Dec 31, receives $515K lump sum.","Todd Young joined as CFO on Oct 27; company initiated search for new COO, duties assumed by other executives."],"consensus_eps_estimate":null,"consensus_eps_actual":0.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":2491310000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121210,"accession_number":"0001193125-25-233507","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-10-07T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare appoints Todd Young as CFO effective Oct 27, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Todd Young, former Elanco Animal Health CFO, appointed as Acadia Healthcare CFO effective Oct 27, 2025.","Young receives $725K annual base salary, target cash bonus of 85% of base, and one-time cash award of $460K.","Interim CFO Tim Sides will resume role as Senior VP, Operations Finance after Young's start date.","Severance package includes 12 months salary, pro-rated bonus, and full vesting of time-based equity upon qualifying termination.","Young previously served as CFO at ACADIA Pharmaceuticals (2016-2018) and Elanco Animal Health since 2018."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137858,"accession_number":"0001193125-25-221545","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Acadia Healthcare 2026 capex to drop at least $300M; Q3 same-facility patient days up 1.3%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total 2026 capex expected to decline at least $300M from 2025 guidance of $600-$650M.","Expects to add 500-700 beds in 2026, inclusive of beds under construction in 2025.","Q3 2025 same facility patient days growth approximately 1.3% to date.","Management participating in Jefferies 2025 Healthcare Services Conference fireside chat."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137857,"accession_number":"0001437749-25-024875","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Acadia Q2 revenue $869M (+9.2%), adjusted EPS $0.83; CFO Dixon resigns, Sides interim","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $869.2M (+9.2% YoY); same-facility revenue +9.5% with 7.5% higher rev/patient day.","GAAP net income $30.1M ($0.33 EPS); adjusted income $74.8M ($0.83 EPS); Adj. EBITDA $201.8M (+7.6%).","Added 101 newly licensed beds in Q2; company provides updated 2025 guidance.","CFO Heather Dixon resigns effective Aug 15, 2025; departure not due to disagreement with management.","Timothy Sides appointed Interim CFO (Aug 16); base $445k, weekly supplement $6,140, retention bonus $500k."],"consensus_eps_estimate":null,"consensus_eps_actual":0.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":1639737000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155238,"accession_number":"0001193125-25-132208","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Acadia Healthcare annual meeting elects four directors, approves compensation plan amendment, ratifies EY","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Four Class II directors elected: Bernhard 77.5M for, Grieco 71.9M, Kelly 75.6M, Waud 63.6M (broker non-votes 2.2M).","Amendment to Incentive Compensation Plan approved: 76.9M for, 3.9M against, 39K abstain, 2.2M broker non-votes.","Non-binding advisory vote on named executive officer compensation approved: 74.2M for, 6.6M against.","Frequency of advisory vote set at one year (77.7M votes for 1 year); board adopts annual frequency.","Ernst & Young ratified as independent auditor for FY2025: 80.4M for, 2.6M against, 35K abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155237,"accession_number":"0001437749-25-016141","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q1 revenue $770.5M, net income $8.4M, affirms FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $770.5M, up 0.3% YoY from $768.1M; same-facility revenue +2.1%, patient days +2.2%.","Net income $8.4M ($0.09 diluted EPS); adjusted income $36.9M ($0.40 adjusted EPS).","Adjusted EBITDA $134.2M, includes ~$5M hit from one facility closure in Q1.","Added 378 new licensed beds in Q1 (90 to existing, 288 from new construction).","Full-year 2025 guidance reaffirmed; no specific numeric outlook provided."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":770505000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173753,"accession_number":"0001193125-25-051083","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Acadia Healthcare prices $550M 7.375% senior notes due 2033 to repay revolver","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $550M aggregate principal of 7.375% Senior Notes due March 15, 2033.","Proceeds used to prepay outstanding borrowings under existing senior secured revolving credit line.","Notes offered at par; interest payable semi-annually starting Sep 15, 2025.","Offering upsized from previously announced $500M; closed on March 10, 2025.","Notes are senior unsecured obligations, guaranteed by certain subsidiaries."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173752,"accession_number":"0001193125-25-042573","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Acadia Healthcare enters $1.65B senior secured credit facility, extends maturities to 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $1B revolver and $650M term loan, both due Feb 28, 2030; replaces $600M revolver and term loan due Mar 2026.","On closing, $650M term loan fully drawn and $550M revolver drawn; used to refinance $1.156B existing debt.","Interest at SOFR + 1.375%-2.250% or base rate + 0.375%-1.250% based on leverage; commitment fee 0.20%-0.35%.","Covenants: Total Net Leverage ≤ 5.0x (up to 5.5x for acquisitions), Interest Coverage ≥ 3.0x.","Term loan amortization starts at 2.5% in year 1, rises to 10% in year 5; secured by substantially all assets excluding realty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173751,"accession_number":"0001437749-25-005467","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q4 2024 revenue $774.2M (+4.2%); adj. EPS $0.64; announces $300M buyback","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 net income $32.6M ($0.35 diluted EPS); adjusted income $59.2M ($0.64 diluted EPS).","Same-facility revenue +4.7% YoY on patient days +3.2% and revenue per patient day +1.4%.","Adjusted EBITDA $153.1M, including $14.3M professional liability reserve adjustment and $5.0M facility closure impact.","Added 577 newly licensed beds in Q4; completed ~1,300 newly constructed beds in FY2024.","Board authorized new $300M share repurchase program; FY2025 and Q1 2025 guidance provided."],"consensus_eps_estimate":null,"consensus_eps_actual":2.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":3153963000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173750,"accession_number":"0001193125-25-005003","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["2.02"],"status":"ready","headline":"Acadia Healthcare Q4 same-facility patient days +3.2% YoY, in-line with prior guidance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Same-facility patient days for Q4 2024 grew 3.2% year-over-year.","Growth was within the expected range communicated on October 31, 2024.","Management presented the update at the J.P. Morgan Healthcare Conference.","No revenue, EPS, or other financial results were disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190733,"accession_number":"0001437749-24-032658","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Q3 revenue $815.6M (+8.7%), adj. EPS $0.91; margins expand","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Revenue $815.6M, up 8.7% YoY; adjusted EBITDA $194.3M, up 10.5% YoY (excl. provider relief funds).","Net income $68.1M ($0.74 diluted); adjusted net income $84.1M ($0.91 adjusted diluted EPS).","Same-facility revenue +8.6%: patient days +4.7%, revenue per patient day +3.6%.","Same-facility adjusted EBITDA margin improved 100 bps to 29.7% from Q3 2023.","Company updated 2024 financial guidance (specific figures not provided in excerpt)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":2379725000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207212,"accession_number":"0001193125-24-227393","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-09-27T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Acadia Healthcare receives federal subpoenas over admissions, billing practices","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Voluntary request from US Attorney's Office (SDNY) and grand jury subpoena from Western District of Missouri.","Subsidiary Lakeland Hospital Acquisition also received a grand jury subpoena on same matter.","Investigations focus on admissions, length of stay, and billing; Acadia fully cooperating.","Company anticipates similar document requests from SEC and possibly other agencies.","Acadia states it cannot currently predict the outcome or potential impact on operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207211,"accession_number":"0001437749-24-024148","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q2 revenue up 8.8% to $796M; adj. EPS $0.91 provides updated 2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $796.0M (+8.8% YoY); same-facility revenue +8.3% (patient days +2.6%, revenue/patient day +5.6%).","Net income $78.5M ($0.85 diluted EPS); adjusted income $83.6M ($0.91 diluted EPS).","Adjusted EBITDA $187.6M (+7.6% YoY).","Added 37 beds to existing facilities; opened a 100-bed de novo facility in Mesa, AZ.","Company updated its 2024 financial guidance (details in press release)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":1564091000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224576,"accession_number":"0001193125-24-146576","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.02","5.03","5.07","9.01"],"status":"ready","headline":"Acadia Healthcare appoints Dr. Nasser Khan as COO; board declassified","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Nasser Khan appointed COO effective June 30, 2024; base salary $515,000, target bonus 85%.","John Hollinsworth retiring as EVP of Operations effective June 30, 2024; consulting through Dec 31, 2024 at $10k/month.","Stockholders approved amendment to declassify board of directors at May 23, 2024 annual meeting.","Annual meeting results: Class I directors elected, say-on-pay approved (84.8M for), Ernst & Young ratified as auditor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224575,"accession_number":"0001437749-24-014205","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q1 revenue up 9.1% to $768.1M, adjusted EBITDA up 14.9%, affirms FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $768.1M (+9.1% YoY); same-facility revenue +9.2%; net income $76.4M ($0.83 diluted EPS).","Adjusted EBITDA $173.9M (+14.9%); adjusted EBITDA margin 22.6% (+110 bps YoY); adjusted EPS $0.84.","Affirmed full-year 2024 guidance; added 27 beds, opened one de novo facility, acquired one specialty provider and three CTCs.","Opened 100-bed acute care hospital in Mesa, AZ in April 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":0.83,"consensus_revenue_estimate":null,"consensus_revenue_actual":768051000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}